Are metabolic risk factors and target organ damage more frequent in masked hypertension than in white coat hypertension?
Yoon
Hyun Ju
HJ
Chonnam National University Hospital, Gwangju, Korea.
Ahn
Youngkeun
Y
Park
Jeong Bae
JB
Park
Chang Gyu
CG
Youn
Ho Joong
HJ
Choi
Dong Ju
DJ
Shin
Joon-Han
JH
Kim
Dong-Woon
DW
Rim
Se Joong
SJ
Bae
Jang Ho
JH
D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage; D000959:Antihypertensive Agents / Q000008:administration & dosage; D001786:Blood Glucose / Q000378:metabolism; D001794:Blood Pressure / Q000187:drug effects; D018660:Blood Pressure Monitoring, Ambulatory; D005260:Female; D006801:Humans; D006973:Hypertension / Q000175:diagnosis* / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology* / Q000628:therapy; D007723:Korea; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012307:Risk Factors
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D001786:Blood Glucose; D008055:Lipids